Get the Stockscreener App
66.97
1.30%
-0.88
Overview
News
Price History
Option Chain
Financials
Why CVS Down?
Discussions
Forecast
Stock Split
Dividend History
Cvs Health Corp stock is traded at $66.97, with a volume of 5.91M.
It is down -1.30% in the last 24 hours and down -4.57% over the past month.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 27 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all existing business lines.
See More
Previous Close:
$67.85
Open:
$67.73
24h Volume:
5.91M
Relative Volume:
0.59
Market Cap:
$85.34B
Revenue:
$378.96B
Net Income/Loss:
$5.28B
P/E Ratio:
15.98
EPS:
4.19
Net Cash Flow:
$5.94B
1W Performance:
-0.73%
1M Performance:
-4.57%
6M Performance:
+20.58%
1Y Performance:
+20.28%
1-Day Range:
$66.81
$67.76
1-Week Range:
$65.84
$68.52
52-Week Range:
$43.56
$72.51
Cvs Health Corp Stock (CVS) Company Profile
Name
Cvs Health Corp
Sector
Industry
Phone
(401) 765-1500
Address
ONE CVS DR., WOONSOCKET
Compare CVS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
66.97 | 85.34B | 378.96B | 5.28B | 5.94B | 4.19 |
|
UNH
Unitedhealth Group Inc
|
380.64 | 364.02B | 410.06B | 22.11B | 24.86B | 23.88 |
|
ELV
Elevance Health Inc
|
404.58 | 92.63B | 183.12B | 5.92B | 3.67B | 25.63 |
|
CI
Cigna Group
|
333.46 | 89.43B | 254.47B | 5.03B | 6.01B | 18.06 |
|
HUM
Humana Inc
|
249.53 | 31.20B | 117.76B | 1.21B | 2.39B | 9.95 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-12-25 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Jan-30-25 | Upgrade | Edward Jones | Hold → Buy |
| Dec-03-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Nov-18-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-10-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-04-24 | Upgrade | TD Cowen | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| May-07-24 | Downgrade | TD Cowen | Buy → Hold |
| May-02-24 | Downgrade | UBS | Buy → Neutral |
| May-01-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-01-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Dec-22-23 | Initiated | HSBC Securities | Buy |
| Sep-19-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-12-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| May-26-23 | Initiated | Piper Sandler | Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-29-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-11-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-14-21 | Initiated | Goldman | Buy |
| Dec-01-21 | Initiated | Seaport Research Partners | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Mar-17-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jan-08-21 | Upgrade | Jefferies | Hold → Buy |
| Sep-17-20 | Initiated | Piper Sandler | Overweight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-14-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Sep-27-19 | Resumed | RBC Capital Mkts | Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Jun-05-19 | Upgrade | Standpoint Research | Hold → Buy |
| Apr-29-19 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Apr-15-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-10-19 | Reiterated | BofA/Merrill | Buy |
| Mar-13-19 | Initiated | Bernstein | Outperform |
| Feb-20-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jan-17-19 | Initiated | UBS | Buy |
| Dec-18-18 | Initiated | Barclays | Overweight |
| Nov-29-18 | Resumed | Goldman | Neutral |
| Nov-28-18 | Initiated | Evercore ISI | Outperform |
| Oct-26-18 | Resumed | Wolfe Research | Peer Perform |
| Jul-09-18 | Upgrade | Citigroup | Neutral → Buy |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-13-18 | Reiterated | Citigroup | Neutral |
View All
Cvs Health Corp Stock (CVS) Latest News
Zepbound Patients Fear Losing Coverage After CVS Deal for Wegovy - Bloomberg.com
CVS Health Corporation (CVS): Among the Best Performing Large Cap Stocks So Far in 2025 - MSN
Collar Capital Management LLC Makes New $520,000 Investment in CVS Health Co. (NYSE:CVS) - MarketBeat
AG alleges CVS didn’t share discounts with MassHealth members - The Boston Globe
AM Best Affirms Credit Ratings of CVS Health Corporation’s Aetna Inc. Subsidiaries - Stock Titan
CVS Health raises annual profit forecast as turnaround gathers steam - MSN
FY2025 EPS Forecast for CVS Health Increased by Analyst - MarketBeat
Cantor Fitzgerald maintains CVS Health stock at Overweight By Investing.com - Investing.com Nigeria
CVS Hid Prescription Discounts From Medicaid, States Allege - Law360
AG Campbell sues CVS for allegedly overcharging MassHealth for prescriptions - WWLP
JPMorgan raises CVS Health stock target to $86, keeps Overweight rating - Investing.com
CVS Can Arbitrate Clinic Worker's Suit Alleging Illegal Layoffs - Law360
Stocktwits Spotlight: NRx, CVS, ReShape Lead Weekly Jump In Health Care Stock Chatter - MSN
Jim Cramer on CVS Health Corporation (CVS): ‘David Joyner’s Stunning Turnaround Continues’ - Insider Monkey
Glenview Capital Reduces Stake in CVS (CVS) Post Strong Earnings - GuruFocus
Cantor Fitzgerald Boosts Earnings Estimates for CVS Health - Defense World
Leerink Partnrs Has Weak Estimate for CVS Health Q2 Earnings - MarketBeat
Becker Capital Management Inc. Lowers Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
Activist Glenview cuts stake in CVS after strong first-quarter earnings - Reuters
CVS Achieves 25% Return Amid Turnaround Efforts | CVS Stock News - GuruFocus
Activist investor Glenview Capital reduces stake in CVS Health By Reuters - Investing.com
Activist investor Glenview Capital reduces stake in CVS Health - NewsBreak: Local News & Alerts
Activist Investor Glenview Capital Reduces Stake in CVS Health - US News Money
Glenviw issues statement on CVS Health - TipRanks
CVS’s ‘Healthy’ Results Prompts Activist Glenview to Pare Stake - Bloomberg.com
Glenview Capital Reveals How New CVS Leadership Delivered 25% Returns in Just 12 Months - Stock Titan
Cantor Fitzgerald maintains CVS Health stock at Overweight - Investing.com
CVS Health (CVS) Sees Price Target Upgrade by Wells Fargo | CVS Stock News - GuruFocus
CVS Health (CVS) Target Price Boosted by Wells Fargo Amid Perfor - GuruFocus
CVS Health’s SWOT analysis: stock poised for growth amid challenges - Investing.com
RBC Capital Boosts Price Target for CVS to $81 Following Q1 Resu - GuruFocus
CVS (CVS) Embarks on Strategic Shift Amidst Health Sector Challe - GuruFocus
RBC Capital Raises Price Target for CVS Health to $81 | CVS Stock News - GuruFocus
RBC Capital Boosts Price Target for CVS to $81 Following Q1 Results | CVS Stock News - GuruFocus
CVS Health (CVS) Price Target Boosted by Analyst Following Positive Outlook | CVS Stock News - GuruFocus
Comerica Bank Reduces Stock Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS (CVS) Embarks on Strategic Shift Amidst Health Sector Challenges - GuruFocus
2 Healthcare Stocks to Research Further and 1 to Be Wary Of - The Globe and Mail
One68 Global Capital LLC Buys Shares of 80,597 CVS Health Co. (NYSE:CVS) - MarketBeat
8 Knots Management LLC Decreases Stock Position in CVS Health Co. (NYSE:CVS) - MarketBeat
Is CVS Health Corporation (CVS) The Best Stock To Buy and Hold For 10 Years? - Insider Monkey
CVS Health (CVS) Exceeds Earnings Expectations, Analysts Maintain Revenue Forecasts - GuruFocus
What is CVS? 'We are ... working through that very question' - Yahoo Finance
CVS Health rides improving Medicare business to better-than-expected first quarter - LancasterOnline
Northern Trust Corp Acquires 928,833 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health (CVS) Exceeds Q1 Expectations with Revenue and EPS Gains - GuruFocus
12 Best Stocks to Buy and Hold For 10 Years - Insider Monkey
CVS Health Corporation (NYSE:CVS) Q1 2025 Earnings Call Transcript - Insider Monkey
Whitebox Advisors LLC Acquires New Shares in CVS Health Co. (NYSE:CVS) - MarketBeat
Freestone Grove Partners LP Buys Shares of 806,575 CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Rides Improving Medicare Business In First Quarter - Post Journal
Cvs Health Corp Stock (CVS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
1.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):